» Authors » Anna Lisa Palange

Anna Lisa Palange

Explore the profile of Anna Lisa Palange including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 231
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Decuzzi P, Peer D, Di Mascolo D, Palange A, Manghnani P, Moghimi S, et al.
Nanotechnology . 2020 Oct; 32(1):012001. PMID: 33043901
Since the launch of the Alliance for Nanotechnology in Cancer by the National Cancer Institute in late 2004, several similar initiatives have been promoted all over the globe with the...
12.
Ferreira M, Rizzuti I, Palange A, Barbato M, Di Francesco V, di Francesco M, et al.
Front Bioeng Biotechnol . 2020 Mar; 8:5. PMID: 32140459
Fine-tuning loading and release of therapeutic and imaging agents associated with polymeric matrices is a fundamental step in the preclinical development of novel nanomedicines. Here, 1,000 × 400 nm Discoidal...
13.
Colasuonno M, Palange A, Aid R, Ferreira M, Mollica H, Palomba R, et al.
ACS Nano . 2018 Nov; 12(12):12224-12237. PMID: 30427660
Tissue plasminogen activator (tPA) is the sole approved therapeutic molecule for the treatment of acute ischemic stroke. Yet, only a small percentage of patients could benefit from this life-saving treatment...
14.
Palomba R, Palange A, Rizzuti I, Ferreira M, Cervadoro A, Barbato M, et al.
ACS Nano . 2018 Jan; 12(2):1433-1444. PMID: 29314819
The effect of nanoparticle size, shape, and surface properties on cellular uptake has been extensively investigated for its basic science and translational implications. Recently, softness is emerging as a design...
15.
Ameruoso A, Palomba R, Palange A, Cervadoro A, Lee A, Di Mascolo D, et al.
Front Immunol . 2017 Nov; 8:1411. PMID: 29163489
Inflammation is a common hallmark in several diseases, including atherosclerosis, cancer, obesity, and neurodegeneration. In Alzheimer's disease (AD), growing evidence directly correlates neuronal damage with inflammation of myeloid brain cells,...
16.
Palange A, Palomba R, Rizzuti I, Ferreira M, Decuzzi P
Mol Ther . 2017 Mar; 25(7):1514-1521. PMID: 28341562
Over the last 15 years, a plethora of materials and different formulations have been proposed for the realization of nanomedicines. Yet drug-loading efficiency, sequestration by phagocytic cells, and tumor accumulation...
17.
Key J, Palange A, Gentile F, Aryal S, Stigliano C, Di Mascolo D, et al.
ACS Nano . 2015 Oct; 9(12):11628-41. PMID: 26488177
Most nanoparticles for biomedical applications originate from the self-assembling of individual constituents through molecular interactions and possess limited geometry control and stability. Here, 1000 × 400 nm discoidal polymeric nanoconstructs...
18.
Gizzatov A, Key J, Aryal S, Ananta J, Cervadoro A, Palange A, et al.
Adv Funct Mater . 2015 Jul; 24(29):4584-4594. PMID: 26167143
Iron oxide nanoparticles are formidable multifunctional systems capable of contrast enhancement in magnetic resonance imaging; guidance under remote fields; heat generation; and biodegradation. Yet, this potential is underutilized in that...